We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$469M
AUM Growth
Cap. Flow
+$470M
Cap. Flow %
100.23%
Top 10 Hldgs %
41.12%
Holding
82
New
82
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.2M
2
TIF
Tiffany & Co.
TIF
+$26.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.6M
4
SSYS icon
Stratasys
SSYS
+$19M
5
BF.B icon
Brown-Forman Class B
BF.B
+$18.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 30.3%
2 Technology 13.16%
3 Industrials 12.96%
4 Consumer Staples 11.74%
5 Energy 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAP
76
The Gap Inc
GAP
$7.07B
$280K 0.06%
+6,700
New +$264K
PFE icon
77
Pfizer
PFE
$141B
$226K 0.05%
+8,523
New +$235K

Similar funds

Tirschwell & Loewy's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Tirschwell & Loewy, which disclosed 82 positions worth $469M. Its ten largest holdings account for 41% of the portfolio.

Its largest position is Biogen: 127,475 shares worth $27.4M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, followed by Technology and Industrials.

  • Tirschwell & Loewy's largest Q2 2013 buy was Biogen: 127,475 shares worth $27.4M.
  • Tirschwell & Loewy's ten largest holdings make up 41% of its $469M portfolio in Q2 2013.
  • Tirschwell & Loewy disclosed 82 positions in Q2 2013, its first 13F filing on record.

Based on Tirschwell & Loewy's 13F filing for Q2 2013, filed 30 Jul 2013.